Latest News
RingConn Smart Ring With Sleep Apnea Monitoring Launches at Target.com
LOS ANGELES, May 30, 2025 /PRNewswire/ -- Leading smart ring brand RingConn has officially expanded its retail presence through a partnership with Target, one of the largest and most influential retailers inthe United States. The brand's flagship RingConn Gen 2 Smart Ring, along with accessories,...
SuperMaker AI Launches Free AI Video Platform That Actually Works
SHERIDAN, Wyo., May 30, 2025 /PRNewswire/ -- Here's something cool. SuperMaker
AI
dancemoon Reinvents Itself with Its First Bathroom Essential: the JustHang Squeegee
NEW YORK, May 30, 2025 /PRNewswire/ -- dancemoon, the trailblazer in home cleaning innovation,is excited to announce the launch of its first bathroom essential product: the dancemoon JustHang Squeegee. The product will be available for pre-order in the US startingMay 30 on the brand's official w...
Fosi Audio Debuts 1st MemberFest -- Building a Unique Global HiFi Community
SHENZHEN, China, May 30, 2025 /PRNewswire/ -- Fosi Audio, a brand committed to redefining high-fidelity sound with unmatched value and user-centered innovation, has officially launched its inaugural MemberFest, running fromMay 27 to June 8 (PST). The event celebrates the brand's growing global co...
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)
SHANGHAI, May 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned subsidiary T-mab has officially obtaine...
Bruno Marc Redefines Summer Dressing with the Flex Oxford Collection
Versatile by Nature, Crafted for the Modern Man.
NEW YORK, May 30, 2025 /PRNewswire/ -- This summer, Bruno Marc introduces the
Flex Oxford Collection
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT001
* Preclinical data with BBT002 demonstrate its best-in-disease potential for improved efficacy and dosing convenience across respiratory, dermatology, and gastroenterology indications * Interim safety and pharmacokinetic data from BBT002-01 study anticipated in Q1 2026 * The clearance of BB...
National treasure returned home after 79 years of drifting -- under China-U.S. joint escort
BEIJING, May 30, 2025 /PRNewswire/ -- A news report by China.org.cn on the homecoming of Chinese cultural relics:   National treasure returned home after 79 years of drifting — under China-U.S. joint escort Ten days ago, a commercial flight from Washington D.C. touched down ...
mF International Limited Announces Results of Annual General Meeting
HONG KONG, May 30, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), aHong Kong-based experienced financial trading solution provider, today announced the results of its annual general meeting of shareholders held inHong Kong on May 30, 2025. At t...
China-Europe-America Think Tank Cooperation Forum Athens Dialogue 2025 Held in Athens, Greece
ATHENS, Greece, May 30, 2025 /PRNewswire/ -- On May 27, the "China
-Europe-America Think Tank Cooperation Forum Athens Dialogue 2025" was held in
Athens, over 30 guests invited from China, France, Italy, the United States and
other countries to the Forum.
Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results
XIAMEN, China, May 30, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedMarch 31, 2025. First Quarter 2025 Financial Highlights: * Total revenue...
So-Young Announces Plan to Implement ADS Ratio Change
BEIJING, May 30, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that the Company plans to change the ratio of the Americ...
Elegoo Expands CSR Programs for Social Inclusion, Marking 10 Years of Empowering Creators
SHENZHEN, China, May 30, 2025 /PRNewswire/ -- Elegoo
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal
YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an SCIE-in...
Gaming Reimagined: Infinix GT VERSE Merges Power, Play, and Portability in One Seamless Ecosystem
HONG KONG, May 30, 2025 /PRNewswire/ -- As the global gaming population
surpasses 3 billion
Milvus Hits 35,000 GitHub Stars as AI Developers Embrace Open-Source Vector Database
Most Popular Vector Database on GitHub Powers Thousands of AI Applications
Worldwide
REDWOOD CITY, Calif., May 30, 2025 /PRNewswire/ -- Zilliz
X-Origin AI Introduces Yonbo: The Next-Gen AI Companion Robot Designed for Families
X-Origin AI Launches Its First AI Companion Robot Yonbo on Kickstarter—Meet Your Most Understanding Digital Life Partner for Lifelong Companionship. LOS ANGELES, May 29, 2025 /PRNewswire/ -- X-ORIGIN-AI specializes in the R&D of consumer-grade AI robotics, breaking the constraints of AI as a mere...
Bridal Disrupted: How Azazie Is Transforming the UK Wedding Scene, One Pop-Up at a Time
LOS ANGELES, May 30, 2025 /PRNewswire/ -- Azazie
Concord Healthcare Announces Official Release of the Proton Therapy Large Model
BEIJING, May 29, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the st...
NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA
SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[ 1] SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Austr...
Week's Top Stories
Most Reposted
Digital Identity Co. Modernizes Thailand Immigration Bureau Services with AWS
[Picked up by 314 media titles]
2026-05-28 15:06The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 291 media titles]
2026-05-26 10:30Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific
[Picked up by 289 media titles]
2026-05-28 17:34ASEAN Business Advisory Council (ASEAN-BAC) and AVPN Establish Regional Platform to Strengthen Corporate Social Investment and Cross-Sector Collaboration Across Southeast Asia
[Picked up by 288 media titles]
2026-05-28 10:06Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
[Picked up by 288 media titles]
2026-05-27 09:16